Salesforce, Inc.

Salesforce, Inc. Q4 FY2017 earnings

CRM

Quarter ended Jan 2017.

← Q3 FY2017Q1 FY2018 →
Revenue
$2.29B
+26.8% YoY
Gross margin
72.7%
-2.8 pp YoY
Operating margin
-1.0%
-2.2 pp YoY
Net income
-$51.4M
-101.7% YoY

Summary

CRM's fiscal Q4 2017 demonstrates the company's aggressive growth strategy through acquisitions and continuous investment in expanding its cloud offerings. During the fiscal year, CRM acquired Demandware, Quip, and Krux, with Demandware being the most sizable at $2.9 billion. These acquisitions align with CRM's strategy to bolster its digital commerce and enhance services across its platform. However, these moves have not come without cost, notably resulting in significant expenses attributed to equity awards and amortization of purchased intangibles.

Revenue for fiscal year 2017 saw notable increases across its core service offerings: Sales Cloud revenue rose to $3,060.6 million, up 13% from the previous fiscal year, and Service Cloud revenue jumped 28% to $2,320.7 million. The Salesforce Platform and Other revenues increased by 39% to $1,441.6 million. Marketing Cloud, boosted by the Demandware acquisition, grew by 43% to $933.3 million, with 11% of this attributed to Demandware alone.

A potentially concerning point is the attrition rate that remained at eight to nine percent, echoing past performance levels. As CRM aims to expand its reach and customer base, managing attrition rates effectively remains pivotal to sustaining long-term growth and competitive standing.

CRM continues to face risks associated with integrating acquisitions, which can pose challenges in maintaining or elevating existing standards and brand reputation. Additionally, while marketing and sales expenses constitute a substantial 47% of total revenues, this also paints a picture of CRM's commitment to market share growth and brand visibility.

Looking forward, the company intends to push the envelope with plans to further increase data center capacity and broaden its workforce, particularly within direct sales and R&D. The moves are indicative of CRM's dedication to meeting future demand and maintaining its pace of growth within the competitive cloud industry landscape.

CRM's cautious expenditure projections underscore the need to balance expansion aspirations against fiscal prudence, given that the company has capital commitments extending over multiple years, such as facilities space and equipment leases, exceeding $6 billion. This necessitates closely monitored financial management alongside ongoing implementation of effective integration strategies for the slew of new acquisitions.

Forecast

Management guidance

No forward guidance in this quarter's filings.

Reported figures

GAAP, from SEC filings
MetricQ4 FY2017Q3 FY2017QoQQ4 FY2016YoY
Revenue$2.29B$2.14B+7.0%$1.81B+26.8%
Gross profit$1.67B$1.56B+7.0%$1.37B+22.1%
Gross margin72.7%72.7%+0.0 pp75.5%-2.8 pp
Research & development$344.2M$311.5M+10.5%$250.9M+37.2%
Sales & marketing$1.09B$998.0M+9.1%$890.4M+22.3%
General & administrative$257.9M$246.8M+4.5%$203.9M+26.5%
Total operating expenses$1.69B$1.56B+8.7%$1.35B+25.7%
Operating income (loss)-$23.3M$3.0M-868.9%$20.6M-213.5%
Operating margin-1.0%0.1%-1.2 pp1.1%-2.2 pp
Net income (loss)-$51.4M-$37.3M-37.9%-$25.5M-101.7%
Net margin-2.2%-1.7%-0.5 pp-1.4%-0.8 pp
Diluted EPS-$0.07-$0.05-$0.02-$0.04-$0.03

Risks

MEDIUMAcquisition Integration

The company faces challenges in integrating newly acquired businesses, which could impact brand consistency and quality standards, potentially harming the business if not managed well.

MEDIUMSubscription Attrition

Subscription attrition rates are projected to stay between eight and nine percent, matching previous levels. Given the company's expansion plans, maintaining or improving attrition is crucial to success.

Summary, forecast, risks and KPIs are extracted from Salesforce, Inc.'s SEC filings for Q4 FY2017 (10-Q / 10-K and the 8-K earnings release); GAAP figures in the summary are checked against the reported XBRL data. They can contain errors; the filings are authoritative. Processed Aug 4, 2026.